SCHEMBL28757134

SCHEMBL28757134

Nc1ncnc2c1c(I)nn2C1CCC(C(=O)O)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 5/20 0.73
▸ JAK2 O60674 4/20 0.73
▸ KDR P35968 3/20 0.73
▸ DYRK3 O43781 2/20 0.73
▸ CDK1 P06493 2/20 0.73
▸ ROS1 P08922 2/20 0.73
▸ RPS6KB1 P23443 2/20 0.73
▸ CDK2 P24941 2/20 0.73
▸ CSNK1A1 P48729 2/20 0.73
▸ CSNK1D P48730 2/20 0.73
▸ CLK2 P49760 2/20 0.73
▸ IRAK1 P51617 2/20 0.73
▸ CDK5 Q00535 2/20 0.73
▸ DYRK1A Q13627 2/20 0.73
▸ NTRK3 Q16288 2/20 0.73
▸ SLK Q9H2G2 2/20 0.73
▸ CLK4 Q9HAZ1 2/20 0.73
▸ LCK P06239 2/20 0.73
▸ SRC P12931 2/20 0.73
▸ CDC7 O00311 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL27088025 0.92 RET (0.80) RETJAK2KDRDYRK3CDK1
SCHEMBL29999054 0.88 JAK2 (0.86) RETJAK2KDRDYRK3CDK1
SCHEMBL24096480 0.88 JAK2 (0.86) RETJAK2KDRDYRK3CDK1
SCHEMBL28757083 0.86 RET (0.60) RETJAK2KDRDYRK3CDK1
Acetic Acid SCHEMBL30320621 0.85 RET (0.73) RETJAK2KDRDYRK3CDK1
SCHEMBL28423335 0.84 RET (0.68) RETJAK2KDRDYRK3CDK1
SCHEMBL17267662 0.84 RET (0.68) RETJAK2KDRDYRK3CDK1
SCHEMBL16594430 0.84 RET (0.68) RETJAK2KDRDYRK3CDK1
SCHEMBL6109435 0.84 KDR (1.00) RETJAK2KDRDYRK3CDK1
SCHEMBL6109045 0.84 KDR (1.00) RETJAK2KDRDYRK3CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 — — CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 — — CN disclosed
Send feedback